Shuttle Pharmaceuticals Holdings Inc (SHPH)
0.871
-0.01
(-1.25%)
USD |
NASDAQ |
Nov 22, 16:00
0.89
+0.02
(+2.18%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings Cash from Financing (Quarterly): -0.1968M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.1968M |
| June 30, 2024 | -0.4617M |
| March 31, 2024 | -0.04M |
| December 31, 2023 | -0.3344M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.1392M |
| March 31, 2023 | 3.044M |
| December 31, 2022 | -0.0674M |
| Date | Value |
|---|---|
| September 30, 2022 | 10.12M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.5257M |
| December 31, 2021 | 0.4949M |
| September 30, 2021 | 0.12M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.073M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.4617M
Minimum
Jun 2024
10.12M
Maximum
Sep 2022
0.8759M
Average
--
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| Oragenics Inc | 3.766M |
| Lixte Biotechnology Holdings Inc | 0.00 |
| Soligenix Inc | 3.293M |
| Tonix Pharmaceuticals Holding Corp | 42.90M |
| NovaBay Pharmaceuticals Inc | 2.089M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.999M |
| Cash from Investing (Quarterly) | 1.656M |
| Free Cash Flow | -5.699M |
| Free Cash Flow Per Share (Quarterly) | -0.8383 |
| Free Cash Flow Yield | -305.4% |